Computer-aided diagnosis of Parkinson's disease based on [123I]FP-CIT SPECT binding potential images, using the voxels-as-features approach and support vector machines
Objective. The aim of the present study was to develop a fully-automated computational solution for computer-aided diagnosis in Parkinson syndrome based on [123I]FP-CIT single photon emission computed tomography (SPECT) images. Approach. A dataset of 654 [123I]FP-CIT SPECT brain images from the Park...
Saved in:
Published in | Journal of neural engineering Vol. 12; no. 2; pp. 26008 - 26017 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
IOP Publishing
01.04.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective. The aim of the present study was to develop a fully-automated computational solution for computer-aided diagnosis in Parkinson syndrome based on [123I]FP-CIT single photon emission computed tomography (SPECT) images. Approach. A dataset of 654 [123I]FP-CIT SPECT brain images from the Parkinson's Progression Markers Initiative were used. Of these, 445 images were of patients with Parkinson's disease at an early stage and the remainder formed a control group. The images were pre-processed using automated template-based registration followed by the computation of the binding potential at a voxel level. Then, the binding potential images were used for classification, based on the voxel-as-feature approach and using the support vector machines paradigm. Main results. The obtained estimated classification accuracy was 97.86%, the sensitivity was 97.75% and the specificity 98.09%. Significance. The achieved classification accuracy was very high and, in fact, higher than accuracies found in previous studies reported in the literature. In addition, results were obtained on a large dataset of early Parkinson's disease subjects. In summation, the information provided by the developed computational solution potentially supports clinical decision-making in nuclear medicine, using important additional information beyond the commonly used uptake ratios and respective statistical comparisons. (ClinicalTrials.gov Identifier: NCT01141023) |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1741-2560 1741-2552 |
DOI: | 10.1088/1741-2560/12/2/026008 |